Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Creative Media & Community Trust | CMCT | Jan 23, 2025 | 0.77 | -2.90 |
Creative Medical Technology | CELZ | Jan 23, 2025 | 2.40 | -2.44 |
Creative Realities | CREX | Jan 23, 2025 | 2.51 | -1.57 |
Credicorp | BAP | Jan 23, 2025 | 182.25 | -0.32 |
Credit Acceptance | CACC | Jan 23, 2025 | 524.14 | +3.73 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Jan 23, 2025 | 26.55 | -0.84 |
Credit Suisse Ag | GLDI | Jan 23, 2025 | 156.83 | +0.01 |
Credit Suisse Ag | SLVO | Jan 23, 2025 | 76.50 | -0.52 |
Credit Suisse Asset Management Income Fund | CIK | Jan 23, 2025 | 2.94 | -0.17 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Jan 23, 2025 | 65.18 | -1.15 |
Credit Suisse High Yield Bond Fund | DHY | Jan 23, 2025 | 2.14 | +0.47 |
Credo Technology | CRDO | Jan 23, 2025 | 84.18 | -1.54 |
Crescent Capital BDC | CCAP | Jan 23, 2025 | 19.59 | +0.67 |
Crescent Energy | CRGY | Jan 23, 2025 | 16.34 | +1.11 |
Cresud A ADR | CRESY | Jan 23, 2025 | 12.75 | -0.16 |
Crexendo | CXDO | Jan 23, 2025 | 5.77 | +2.12 |
CRH | CRH | Jan 23, 2025 | 100.52 | +0.19 |
Cricut A | CRCT | Jan 23, 2025 | 5.94 | +2.06 |
Crinetics Pharmaceuticals | CRNX | Jan 23, 2025 | 39.20 | +1.42 |
CRISPR Therapeutics | CRSP | Jan 23, 2025 | 44.23 | +0.07 |
Criteo ADR | CRTO | Jan 23, 2025 | 37.84 | -1.23 |
Critical Metals | CRML | Jan 23, 2025 | 7.35 | -2.78 |
Crocs | CROX | Jan 23, 2025 | 105.06 | +2.36 |
Cronos Group | CRON | Jan 23, 2025 | 1.93 | +0.52 |
Cross Country Healthcare | CCRN | Jan 23, 2025 | 18.25 | +0.33 |
Cross Timbers Royalty Royalty Trust | CRT | Jan 23, 2025 | 11.11 | +6.52 |
CrossAmerica Partners LP Unit | CAPL | Jan 23, 2025 | 22.16 | +1.28 |
CrossFirst Bankshares | CFB | Jan 23, 2025 | 15.22 | +1.60 |
CrowdStrike A | CRWD | Jan 23, 2025 | 377.70 | -0.07 |
Crown Castle | CCI | Jan 23, 2025 | 88.64 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.